These systemic diseases share in common with primary central nervous system (CNS) degenerative diseases, impairments in cognition, and deficits in insulin and IGF signaling mechanisms, insulin/IGF responsive gene expression, and energy metabolism (glucose utilization) in the brain, including cerebellum [29,75-78]. Here, IGF1 is linked to neurodegenerative disease.